Add Company
Join Now

MAPS Public Benefit Corporation (MAPS PBC) Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • MAPS Public Benefit Corporation (MAPS PBC)'s estimated annual revenue is currently $19.6M per year.(i)
  • MAPS Public Benefit Corporation (MAPS PBC)'s estimated revenue per employee is $112,200

Employee Data

  • MAPS Public Benefit Corporation (MAPS PBC) has 175 Employees.(i)
  • MAPS Public Benefit Corporation (MAPS PBC) grew their employee count by 46% last year.

MAPS Public Benefit Corporation (MAPS PBC)'s People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief StaffReveal Email/Phone
3
Chief Therapy TrainingReveal Email/Phone
4
Head DevelopmentReveal Email/Phone
5
Head Marketing & Brand LeadReveal Email/Phone
6
Director, Financial Planning & AnalysisReveal Email/Phone
7
Associate Director Adherence & SupervisionReveal Email/Phone
8
Director Clinical OperationsReveal Email/Phone
9
Chief Scientific OfficerReveal Email/Phone
10
Senior Director, Medical Education, Communications & ReviewReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24M21410%N/AN/A
#2
$4.8M52-4%N/AN/A
#3
$2.9M369%N/AN/A
#4
$22.4M2005%N/AN/A
#5
$1.7M249%N/AN/A
#6
$10.1M99-1%N/AN/A
#7
$5.8M639%N/AN/A
#8
$3.2M39N/AN/AN/A
#9
$5.8M63-3%N/AN/A
#10
$0.8M13N/AN/AN/A
Add Company

What Is MAPS Public Benefit Corporation (MAPS PBC)?

MAPS Public Benefit Corporation (MAPS PBC) is a wholly-owned subsidiary of the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS). The special purpose of MAPS PBC is to balance the research and clinical development objectives with the social benefits of MAPS' mission by serving as a vehicle for conducting MAPS' psychedelic and marijuana research initiatives. MAPS PBC's primary work is completing clinical studies of MDMA-assisted therapy for PTSD, and preparing for the pathway to licensure for MDMA-assisted therapy as an approved treatment for PTSD and other anxiety-related disorders. In addition, MAPS PBC is also investigating marijuana as a treatment for PTSD in Veterans through upcoming clinical trials. MAPS will continue to conduct education and harm reduction projects to raise funds for MAPS PBC projects, and serve as the parent organization and sole funder of MAPS PBC. MAPS PBC was incorporated on December 19, 2014.

keywords:N/A

N/A

Total Funding

175

Number of Employees

$19.6M

Revenue (est)

46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MAPS Public Benefit Corporation (MAPS PBC) News

2022-04-13 - Numinus to Acquire Novamind, Creating the North American ...

... clinical trials for MDMA (MAPS Public Benefit Corporation), ... hosted in collaboration with MAPS Public Benefit Corporation (MAPS PBC);...

2022-03-30 - Numinus Administers MDMA To First Volunteer In Clinical Trial Sponsored By MAPS - Benzinga

... by the Multidisciplinary Association for Psychedelic Studies (MAPS) and organized by MAPS Public Benefit Corporation (MAPS PBC).

2022-03-30 - Numinus Completes First MDMA Administration in PTSD Trial ...

... Psychedelic Studies (MAPS) and organized by MAPS Public Benefit Corporation (MAPS PBC), by enrolling and dosing the first clinical trial...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$52.3M1765%N/A
#2
$43.1M178-5%N/A
#3
$75M1793%N/A
#4
$15M1798%N/A
#5
$51.1M1858%N/A